719 — Shandong Xinhua Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$4.87bn
- HK$5.50bn
- CNY8.47bn
- 63
- 84
- 14
- 55
Annual cashflow statement for Shandong Xinhua Pharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -1,547 | -1,556 | -1,771 | -1,939 | -1,877 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 420 | 259 | 758 | 265 | 368 |
| Capital Expenditures | -280 | -249 | -245 | -325 | -212 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -17.8 | 11.5 | 15.9 | 20 | 0.211 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -298 | -238 | -229 | -305 | -212 |
| Financing Cash Flow Items | 465 | 17 | 87.2 | -397 | 102 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 35 | -140 | -131 | -196 | 185 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 145 | -126 | 414 | -229 | 355 |